" class="no-js "lang="en-US"> Cancers Archives - Medtech Alert
Tuesday, March 19, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Ariceum Therapeutics Expands Pipeline with Acquisition of Theragnostics

Ariceum Therapeutics, a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of […]

Antengene Announces Antibody-Drug Conjugate Granted Orphan Drug Designations by the FDA for the Treatment of Gastric and Pancreatic Cancers

Antengene Corporation, a leading commercial-stage innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing […]

Ratio Therapeutics Announces Licensing Agreement for Investigational PET Imaging Agent with Merck

Ratio Therapeutics, a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class […]

FLASH Proton Therapy Clinical Trial Begins on Cancers Involving Bones in the Chest

Treatment of the first participant in a clinical trial of FLASH proton therapy for cancers […]

Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing

Flare Therapeutics, a biotechnology company targeting transcription factors to discover precision medicines for cancer and […]

BiPER Therapeutics Raises €1.25 Million in Seed Funding to Develop First-in-class Small Molecules to Treat Gastrointestinal Cancers

BiPER Therapeutics, a preclinical biotechnology company developing first-in-class drug candidates targeting BiP protein to treat […]

Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer

Treadwell Therapeutics, a clinical-stage, global biotechnology company developing novel, first-in-class therapeutics for highly aggressive cancers, […]

RefleXion Receives FDA Clearance for Biology-Guided Radiotherapy Treatment for Early and Late-stage Cancers

RefleXion Medical, a therapeutic oncology company, today announced the US Food and Drug Administration (FDA) […]

Qurient Announces Dosing of First Patient in Clinical Study for the Treatment of Patients with Solid Tumors

Qurient, a clinical-stage biotech company based in Korea, has announced that the first patient has […]

CNS Pharmaceuticals Appoints Faith L. Charles, JD as Chair of the Board of Directors

CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more